13 sept. 2017 - Potential for use of macrocyclic peptide encompassing the L2 loop sequence from HHIP to disrupt SHH binding as a therapy.
Description:
Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog pathwayAjouté au bande de temps:
Date:
13 sept. 2017
Maintenaint
~ Il y a 8 ans